- 101. NANDROLONE PHENPROPIONATE
- (UMLS (NCI) C0068397) =Steroid; Pharmacologic Substance ;
=19 nortestosterone;
=NANDROLONE PHENPROPIONATE 50 MG/ML;
NANDROLONE PHENPROPIONATE 25 MG/ML;
| - 151. NASAL BONE FX-CLOSED
- [ ] (UMLS (ICD9CM) C0159322) =Injury or Poisoning
|
- 102. Nanirnavirus
- [ ] (UMLS (CSP) C0599135) =Virus
| - 152. NASAL BONE FX-OPEN
- [ ] (UMLS (ICD9CM) C0159323) =Injury or Poisoning
|
- 103. nano
- [A unit prefix indicating a quantity of 10E-9 or one one-billionth. ( NCI )] (UMLS (HL7) C1553036) nano-;
=Quantitative Concept =UnitOfMeasurePrefixSens;
UnitOfMeasurePrefixInsens | - 153. Nasal Cartilage
- (UMLS (NCI) C0225415) =Body Part, Organ, or Organ Component
|
- 104. Nanocurie
- [A unit of radioactivity equal to one billionth of curie or 37 becquerels, and corresponding to a radioactivity of 37 atomic disintegrations per second. ( NCI )] (UMLS (NCI) C0560007) =Quantitative Concept
| - 154. Nasal Cavity
- [The proximal portion of the respiratory passages on either side of the nasal septum, lined with ciliated mucosa, extending from the nares to the pharynx. (MeSH) ( NCI )] (UMLS (NCI) C0027423) =Body Space or Junction ;
|
- 105. NANOG
- [This gene plays a role in the underlying pluripotency of inner cell mass and embryonic stem cells. ( NCI )] (UMLS (NCI) C1427164) NANOG Gene;
Nanog Homeobox Gene;
=Gene or Genome ;
| - 155. Nasal Cavity and Paranasal Sinus Disorder
- (UMLS (NCI) C1334924) =Disease or Syndrome ;
|
- 106. Nanogram
- [LITERAL ( NCI )] (UMLS (NCI) C0439212) =Quantitative Concept
| - 156. Nasal Cavity and Paranasal Sinus Neoplasm
- (UMLS (NCI) C1334925) =Neoplastic Process ;
|
- 107. Nanogram per Deciliter
- [A unit of mass concentration defined as the concentration of one nanogram of a substance in unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one nanogram occupies the volume one deciliter. ( NCI )] (UMLS (NCI) C0439274) =Quantitative Concept
| - 157. Nasal Cavity Disease
- (UMLS (NCI) C0339820) =Disease or Syndrome ;
|
- 108. Nanomaterial
- [A bulk material composed of discrete nano-substructures that are engineered, synthesized and characterized for a myriad of applications. ( NCI )] (UMLS (NCI) C1450053) =Manufactured Object ;
| - 158. Nasal Cavity Neoplasm
- (UMLS (NCI) C0345630) =Neoplastic Process
|
- 109. nanomedicine
- [health related nanotechnology application. ( CSP )] (UMLS (CSP) C1328814) =Occupation or Discipline ;
=Nanoscale Science;
| - 159. Nasal Cavity Non-Hodgkin Lymphoma
- (UMLS (NCI) C1334922) Nasal Cavity Non-Hodgkin's Lymphoma;
Non-Hodgkin's Lymphoma of Nasal Cavity;
Non-Hodgkin's Lymphoma of the Nasal Cavity =Neoplastic Process ;
|
- 110. Nanometer
- [A metric unit of length equal to to one billionth of a meter (10E-9 meter). Nanometer is used as a unit for light wavelength measurement. ( NCI )] (UMLS (NCI) C0439202) =Quantitative Concept
| - 160. Nasal Cavity Olfactory Neuroblastoma
- [An olfactory neuroblastoma arising in the nasal cavity. ( NCI )] (UMLS (NCI) C1334923) Olfactory Neuroblastoma of Nasal Cavity;
Olfactory Neuroblastoma of the Nasal Cavity;
=Neoplastic Process ;
|
- 111. NANOMOLE
- [LITERAL ( NCI )] (UMLS (NCI) C0439191) =Quantitative Concept
| - 161. Nasal Cavity Polyp
- [Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations. ( MSH )] (UMLS (NCI) C0027430) =Anatomical Abnormality ;
=nasal neoplasm;
polyp |
- 112. Nanoparticle
- [A small, stable particle whose size is measured in nanometers. These particles are used in various biomedical applications in which they can be utilized as drug carriers or imaging agents. Various targeting agents, such as antibodies, drugs, imaging agents, and reporters can be attached to the surface of a nanoparticle. ( NCI )] (UMLS (NCI) C1450054) =Manufactured Object ;
| - 162. Nasal Cavity Squamous Cell Carcinoma
- (UMLS (NCI) C0280333) =Neoplastic Process
|
- 113. Nanoscale Science
- [science involved with manufacturing or engineering one atom or molecule at a time with precise atomic specifications; concerned with materials and systems whose structures and components exhibit novel and significantly improved physical, chemical and biological properties, phenomena and processes because of their small nanoscale size; includes technology to generate and use nanostructures and nanodevices; do not index on projects simply observing and describing physical characteristics at the nanoscale level. ( CSP )] (UMLS (NCI) C0872323) Nanotech;
nanotechnology =Occupation or Discipline ;
=bioengineering;
tag term =nanomedicine;
| - 163. nasal disorder
- [condition in which there is a deviation from or interruption of the normal structure or function of the nose, which includes disorders which extend from the external structure, through the nasal cavity, sinuses and up to the nasopharynx. ( CSP )] (UMLS (CSP) C0028432) =Disease or Syndrome ;
=Otorhinolaryngologic Diseases;
DISEASES OF THE RESPIRATORY SYSTEM;
Respiratory Tract Diseases;
=CHOANAL ATRESIA;
demem mehaaf;
Granuloma, Lethal Midline;
Nasal Obstruction;
ACQ NOSE DEFORMITY;
nasal neoplasm;
Paranasal Sinus Disease;
rhinitis;
RHINOSCLEROMA;
nasal neoplasm;
rhinitis;
sinusitis |
- 114. Nanosphere
- [Self-assembling durable silica spheres that fit inside each other. These spheres range in size from 2 to 50 nanometers and form within seconds. They are small enough to be introduced into the body and have uniform pores that facilitate the controlled release of drugs. The spheres also have the capability to absorb both organic and inorganic substances. For example, nanoparticles can absorb small particles of iron, thereby allowing magnetic control. Thus, the contents of nanospheres can be released upon activation. ( NCI )] (UMLS (NCI) C1257852) =Manufactured Object ;
| - 164. NASAL DX PROC NEC
- (UMLS (ICD9CM) C0176359) =Diagnostic Procedure
|
- 115. Nanotube
- [Fullerene-like nanostructures that consist of graphene cylinders. The ends of the construct are closed with pentagonal-shaped rings. ( NCI )] (UMLS (NCI) C1257851) =Manufactured Object ;
| - 165. nasal epithelium
- [ ] (UMLS (CSP) C0599331) =Tissue ;
|
- 116. NAP2
- [Encoded by human PPBP Gene (Alpha Chemokine CXC Family), secreted 128-aa 14-kDa (precursor) Pro-Platelet Basic Protein is a platelet-derived growth factor that is processed to PBP and CTAP-III. Proteolytic removal of PPBP residues 1-9 produces active peptide CTAP-III/LA-PF4, which stimulates DNA synthesis, mitosis, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion, and synthesis of hyaluronic acid and sulfated glycosaminoglycan, as well as formation and secretion of plasminogen activator. Upon platelet activation, PBP is proteolytically converted to beta thromboglobulin, a homotetramer released when platelets aggregate; CTAP-III is proteolytically converted to NAP2, a potent chemoattractant and activator of neutrophils. (NCI) ( NCI )] (UMLS (NCI) C0132309) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 166. NASAL FUNCTION STUDY
- (UMLS (ICD9CM) C0199420) =Diagnostic Procedure
|
- 117. NAPHAZOLINE
- [An imidazole derivative and a direct-acting sympathomimetic amine with vasoconstrictive activity. Upon ocular administration, naphazoline exerts its effect by acting on alpha-adrenergic receptors in the arterioles of the conjunctiva to produce vasoconstriction, resulting in decreased conjunctival congestion and diminished itching, irritation and redness. ( NCI )] (UMLS (NCI) C0027373) =Organic Chemical; Pharmacologic Substance ;
=imidazole;
[OP800] DECONGESTANTS, TOPICAL OPHTHALMIC =1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-, Monohydrochloride | - 167. NASAL LACERATION SUTURE
- [ ] (UMLS (ICD9CM) C0189030) =Therapeutic or Preventive Procedure
|
- 118. naphtha
- [ ] (UMLS (CSP) C0068407) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 168. NASAL MUCOSITIS (ULCER)
- [ ] (UMLS (ICD9CM) C1719474) Nasal mucositis (ulcerative) =Disease or Syndrome
|
- 119. naphthalene
- [two-ring crystalline aromatic hydrocarbons isolated from coal tar; used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, and preservatives. ( CSP )] (UMLS (CSP) C0027378) =Organic Chemical =carbopolycyclic compound;
PAH =(2S)-2-Methylbutanoic Acid, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester;
6-Methoxy-alpha-methyl-2-naphthaleneacetic Acid;
Mayapple Extract;
1-Naphthylamine;
(2S)-2-Methylbutanoic Acid, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester;
Naphthaleneacetic Acids;
Naphthalenesulfonates;
naphthol;
naphthoquinone;
Tetrahydronaphthalenes;
Carbamothioic Acid, methyl(3-methylphenyl)-, O-2-naphthalenyl Ester;
(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene Methanamine;
[1S-[1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha]]-1,2,6,7,8,8a-Hexahydro-beta,!d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoic Acid;
butenafine;
6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid | - 169. Nasal Mucus
- (UMLS (NCI) C0225392) =Body Substance
|
- 120. Naphthalene
- [A white, volatile, solid polycyclic hydrocarbon with a strong mothball odor. Naphthalene is obtained from either coal tar or petroleum distillation and is primarily used to manufacture phthalic anhydride, but is also used in moth repellents. Exposure to naphthalene is associated with hemolytic anemia, damage to the liver and neurological system, cataracts and retinal hemorrhage. Naphthalene is reasonably anticipated to be a human carcinogen and may be associated with an increased risk of developing laryngeal and colorectal cancer. (NCI05) ( NCI )] (UMLS (NCI) C0027375) =Organic Chemical
| - 170. Nasal Muscle
- (UMLS (NCI) C0224219) =Body Part, Organ, or Organ Component
|
- 121. naphthol
- [Naphthalene derivatives carrying one or more hydroxyl (-OH) groups at any ring position. They are often used in dyes and pigments, as antioxidants for rubber, fats, and oils, as insecticides, in pharmaceuticals, and in numerous other applications. ( MSH )] (UMLS (CSP) C0027387) =Organic Chemical =naphthalene;
=[AM250] TETRACYCLINES;
| - 171. nasal neoplasm
- [new abnormal nasal tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease; includes neoplasm of the external structure, through the nasal cavity, sinuses and up to the nasopharynx. ( CSP )] (UMLS (CSP) C0028433) =Neoplastic Process ;
=Head and Neck Neoplasm;
nasal disorder;
Otorhinolaryngologic Neoplasms;
Neoplasm of Respiratory Tract;
Neoplasm of Skull;
=Nasal Cavity Polyp;
Accessory Sinus Neoplasm;
nasopharyngeal neoplasm;
|
- 122. naphthoquinone
- [naphthalene rings which contain two ketone moieties in any position. ( CSP )] (UMLS (CSP) C0027388) =Organic Chemical =naphthalene;
Benzoquinone Compound =[VT700] VITAMIN K;
ATOVAQUONE | - 172. NASAL OPERATION NEC
- [ ] (UMLS (ICD9CM) C0176374) =Therapeutic or Preventive Procedure
|
- 123. naphthylamine
- [nitrogen substituted aromatic hydrocarbon existing as two different isomers, both carcinogenic and used in dyes. ( CSP )] (UMLS (CSP) C0260030) =Organic Chemical ;
=cyclic amine;
=1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol | - 173. Nasal Prongs*
- (UMLS (HL7) C1549525) =Spatial Concept =drug administration route;
|
- 124. naphthyridine
- [ ] (UMLS (CSP) C0178756) =Organic Chemical ;
| - 174. NASAL REPAIR NEC
- [ ] (UMLS (ICD9CM) C0176373) =Therapeutic or Preventive Procedure
|
- 125. Naphuride
- (UMLS (NCI) C0242512) =Organic Chemical; Pharmacologic Substance
| - 175. Nasal Septum
- [The partition separating the two nasal cavities in the midplane, composed of cartilaginous, membranous and bony parts. ( MSH )] (UMLS (HL7) C0027432) =Body Part, Organ, or Organ Component ;
=Body Part;
|
- 126. Naprosyn
- (UMLS (NCI) C0700017) =Organic Chemical; Pharmacologic Substance ;
| - 176. NASAL SINUS DX PROC NEC
- [ ] (UMLS (ICD9CM) C0176380) =Diagnostic Procedure
|
- 127. Naqua
- (UMLS (NCI) C0740163) =Organic Chemical; Pharmacologic Substance ;
| - 177. NASAL SINUS POLYP NEC
- [ ] (UMLS (ICD9CM) C0155823) =Neoplastic Process
|
- 128. NARATRIPTAN
- (UMLS (NCI) C0540623) =Organic Chemical; Pharmacologic Substance ;
=Indole;
Piperidines;
[CN105] ANTIMIGRAINE AGENTS;
=GR 85548A | - 178. NASAL SINUS REPAIR NEC
- [ ] (UMLS (ICD9CM) C0176389) =Therapeutic or Preventive Procedure
|
- 129. Narcan
- (UMLS (NCI) C0684237) =Organic Chemical; Pharmacologic Substance
| - 179. NASAL SINUS TRANSILLUMIN
- (UMLS (ICD9CM) C0199430) =Diagnostic Procedure
|
- 130. narcissine
- [ ] (UMLS (CSP) C0598686) =Organic Chemical
| - 180. Nasal Turbinate
- [The scroll-like bony plates with curved margins on the lateral wall of the nasal cavity. ( MSH )] (UMLS (NCI) C1266928) =Body Part, Organ, or Organ Component
|
- 131. NARCISSISTIC PERSONALITY
- (UMLS (ICD9CM) C0027402) =Mental or Behavioral Dysfunction ;
| - 181. nasal vasoconstrictor
- [ ] (UMLS (CSP) C0282375) =Pharmacologic Substance
|
- 132. NARCLPSY W/O CAT OTH DIS
- [ ] (UMLS (ICD9CM) C1456241) Narcolepsy in conditions classified elsewhere, without cataplexy;
=Disease or Syndrome ;
| - 182. Nasal Vestibule Papilloma
- (UMLS (NCI) C0339826) =Neoplastic Process ;
|
- 133. NARCOANALYSIS
- [ ] (UMLS (ICD9CM) C1281603) =Therapeutic or Preventive Procedure
| - 183. Nasalcrom
- (UMLS (NCI) C0700883) =Organic Chemical; Pharmacologic Substance ;
|
- 134. Narcolepsy in conditions classified elsewhere
- [ ] (UMLS (ICD9CM) C1456243) =Disease or Syndrome ;
| - 184. Nasalis Muscle
- (UMLS (NCI) C0224221) =Body Part, Organ, or Organ Component
|
- 135. Narcolepsy in conditions classified elsewhere, with cataplexy
- [ ] (UMLS (ICD9CM) C1456242) NARCOLEPSY W CAT OTH DIS;
=Disease or Syndrome ;
| - 185. NasalRoute
- [Nasal ( HL7V3.0 )] (UMLS (HL7) C0521140) =Functional Concept =RouteBySite;
=Inhalation, nasal;
Topical application, nasal;
Instillation, nasal;
Instillation, nasogastric;
|
- 136. NARCOLEPSY W/O CATAPLEXY
- [ ] (UMLS (ICD9CM) C1456240) Narcolepsy, without cataplexy;
=Disease or Syndrome ;
| - 186. Nasogastric
- [Administration through the nose and into the stomach, usually by means of a tube. (FDA) ( NCI )] (UMLS (NCI) C0694637) =Functional Concept =drug administration route;
|
- 137. Narcotan
- (UMLS (NCI) C0701983) =Organic Chemical; Pharmacologic Substance ;
| - 187. Nasolacrimal
- (UMLS (HL7) C1550283) =Body Part, Organ, or Organ Component =Body Part;
|
- 138. Narcotic
- [agent that produces insensibility, somnolence or induces sleep; especially, any derivative, natural or synthetic, of opium or morphine or any substance that has their effects; narcotics have potent analgesic effects associated with significant changes in mood and behavior, and with the potential for dependence and tolerance following repeated administration. ( CSP )] (UMLS (NCI) C0027415) =Pharmacologic Substance; Hazardous or Poisonous Substance =psychopharmacologic agent;
=METHADONE;
opiate alkaloid | - 188. Nasolacrimal Duct
- (UMLS (NCI) C0027437) =Body Part, Organ, or Organ Component ;
|
- 139. Narcotic Antagonist
- [class of drugs used to treat opiate drug addiction. ( CSP )] (UMLS (NCI) C0027410) =Pharmacologic Substance ;
=drug addiction antagonist;
Opioid Receptor Interactions =buprenorphine;
cyclazocine;
nalorphine;
(-)-Naloxone;
NALTREXONE;
| - 189. NASOLACRIMAL DUCT PROBE
- [ ] (UMLS (ICD9CM) C0197397) =Diagnostic Procedure; Therapeutic or Preventive Procedure
|
- 140. narcotic control
- [ ] (UMLS (CSP) C0027411) =Governmental or Regulatory Activity ;
| - 190. Nasopharyngeal
- [region of the body in the respiratory system between the nose and the pharynx at the level of the soft palate, including the nasopharynx, which is nasal part of the pharynx above the level of the soft palate. ( CSP )] (UMLS (HL7) C0027442) =Body Part, Organ, or Organ Component ;
=pharynx;
Body Part =nasal;
|
- 141. Nardil
- (UMLS (NCI) C0701388) =Organic Chemical; Pharmacologic Substance
| - 191. Nasopharyngeal Angiofibroma
- [A morphologic variant of fibroma arising from the nasopharynx. It is characterized by the presence of numerous dilated vascular channels. ( NCI )] (UMLS (NCI) C1367536) Nasopharyngeal Juvenile Angiofibroma =Neoplastic Process
|
- 142. Nariva virus
- [ ] (UMLS (CSP) C0318800) =Virus
| - 192. Nasopharyngeal Cancer, Recurrent
- [The reemergence of nasopharyngeal cancer after a period of remission. ( NCI )] (UMLS (NCI) C0278952) =Neoplastic Process
|
- 143. Naroparcil
- (UMLS (NCI) C0294245) =Carbohydrate; Pharmacologic Substance ;
| - 193. Nasopharyngeal Cancer, Stage I
- [Cancer confined to the nasopharynx. ( NCI )] (UMLS (NCI) C1377917) Stage I Carcinoma of Nasopharynx;
Stage I Carcinoma of the Nasopharynx;
Stage I Nasopharyngeal Cancer;
Stage I Nasopharyngeal Carcinoma;
stage I nasopharynx cancer;
Stage I Nasopharynx Carcinoma;
=Neoplastic Process |
- 144. Narragansett Indian Tribe of Rhode Island
- (UMLS (HL7) C1554387) =Population Group =NativeEntityContiguous;
| - 194. Nasopharyngeal Cancer, Stage II
- [Stage II nasopharynx cancer may be either of the following: (1) stage IIA, in which cancer extends from the nasopharynx to the oropharynx, nasal fossa, or both; (2) stage IIB, in which cancer has spread to nearby lymph nodes or extends to the parapharyngeal area. ( NCI )] (UMLS (NCI) C0278949) =Neoplastic Process
|
- 145. Narrower Than
- [The first concept is at a more detailed level than the second concept. For example, Pennicillin G is narrower than Pennicillin, and vellus hair is narrower than hair. Narrower than is the opposite of broader than. ( HL7V3.0 )] (UMLS (HL7) C1552873) =Idea or Concept =MapRelationship;
| - 195. Nasopharyngeal Cancer, Stage III
- [Cancer that has spread to lymph nodes on both sides of the neck or has spread to nearby bones or sinuses. ( NCI )] (UMLS (NCI) C1377918) Stage III Carcinoma of Nasopharynx;
Stage III Carcinoma of the Nasopharynx;
Stage III Nasopharyngeal Cancer;
Stage III Nasopharyngeal Carcinoma;
stage III nasopharynx cancer;
Stage III Nasopharynx Carcinoma;
=Neoplastic Process |
- 146. nasal
- [By or having to do with the nose. ( NCI )] (UMLS (NCI) C0028429) =Body Part, Organ, or Organ Component =Nasopharyngeal;
Body System, Pulmonary;
Body Part;
=Nasal and Sinuses;
| - 196. Nasopharyngeal diphtheria
- (UMLS (ICD9CM) C0012558) =Disease or Syndrome
|
- 147. NASAL & SINUS DIS NEC
- [ ] (UMLS (ICD9CM) C0029581) =Disease or Syndrome
| - 197. Nasopharyngeal Keratinizing Squamous Cell Carcinoma Stage IIA
- (UMLS (NCI) C1336166) Stage IIA Nasopharyngeal Keratinizing Squamous Cell Carcinoma;
=Neoplastic Process |
- 148. nasal airflow measurement
- [ ] (UMLS (CSP) C0599318) =Diagnostic Procedure ;
| - 198. Nasopharyngeal Keratinizing Squamous Cell Carcinoma Stage IIB
- (UMLS (NCI) C1336189) Stage IIB Nasopharyngeal Keratinizing Squamous Cell Carcinoma;
=Neoplastic Process |
- 149. Nasal and Sinuses
- [air-filled extensions of the respiratory part of the nasal cavity into the frontal, ethmoid, sphenoid, and maxillary cranial bones, lined by the ciliated mucous membranes of the nasal cavity. ( CSP )] (UMLS (NCI) C0030471) =Body Space or Junction ;
=nasal;
Body Part | - 199. Nasopharyngeal Keratinizing Squamous Cell Carcinoma Stage IVC
- (UMLS (NCI) C1336400) Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma =Neoplastic Process
|
- 150. nasal bone
- [Either of two small elongated rectangular bones that together form the bridge of the nose. ( MSH )] (UMLS (CSP) C0027422) =Body Part, Organ, or Organ Component ;
| - 200. nasopharyngeal neoplasm
- [new abnormal nasopharyngeal tissue that grows by excessive cellular division and proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease; nasopharyngeal refers to region of the body in the respiratory system between the nose and the pharynx at the level of the soft palate, including the nasopharynx, which is nasal part of the pharynx above the level of the soft palate. ( CSP )] (UMLS (CSP) C0027439) =Neoplastic Process ;
=Head and Neck Neoplasm;
Nasopharyngeal Diseases;
nasal neoplasm;
Neoplasm of Pharynx;
Neoplasm of Respiratory Tract;
|
home
